The Trump administration's recent waiver permits the distribution of H.I.V. medications, offering some relief to a treatment program that had been halted. However, details on whether preventive drugs are included remain ambiguous. The President's Emergency Plan for AIDS Relief (PEPFAR), a cornerstone initiative since 2003 that has saved over 25 million lives, now faces potential funding cuts, jeopardizing the health of over 20 million individuals, including 500,000 vulnerable children. Experts warn that without adequate treatment, the risk of a resurgence of AIDS could mirror the crisis of the 1980s.
The waiver allows the distribution of H.I.V. medications, but clarity on preventive drugs and other services under PEPFAR remains uncertain, putting the program's future at risk.
PEPFAR has saved over 25 million lives since 2003, but potential consequences from funding freezes could eliminate access for over 20 million people, including 500,000 children.
Collection
[
|
...
]